Hyperbaric oxygen and multiple sclerosis... (1985 study) Skip to main content
RCT Lancet (London, England) 1985

Hyperbaric oxygen and multiple sclerosis: short-term results of a placebo-controlled, double-blind trial.

Barnes MP, Bates D, Cartlidge NE, French JM, Shaw DA, Lancet (London, England), 1985

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers compared 20 daily sessions of oxygen under pressure with 20 daily sessions of normal air at normal pressure in 120 people with long-standing multiple sclerosis.

What They Found

This double-blind trial of 120 patients with chronic multiple sclerosis found no improvement on the main disability scale in either the hyperbaric oxygen group or the control group. The hyperbaric group breathed 100% oxygen at 2 atmospheres absolute for 90 minutes daily for a total of 20 exposures, while controls breathed normal air at normal pressure in the same chamber for a similar length of time. On the Kurtzke functional systems scale, 12 of 51 patients in the hyperbaric oxygen group and 3 of 47 control patients improved, and this was on the subjective bowel and bladder measure only. The abstract notes that medication for urinary symptoms can also produce this degree of improvement, and that none of the patients in this study received such medication.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract reports only short-term results, and the one improvement seen was on a subjective bowel and bladder measure, so it says nothing about longer-term effects.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type RCT
Category Neurological
Source Pubmed
PubMed ID 2857361
Year Published 1985
Journal Lancet (London, England)
MeSH Terms Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Multiple Sclerosis; Random Allocation; Time Factors

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology